Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Italy
Clinical trial register · Italy

Clinical Trials in Italy

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 16 Rome 9 Naples 8 Florence 7 Meldola 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS363 IRCCS Azienda Ospedaliero-Universitaria di Bologna274 AstraZeneca180 IRCCS San Raffaele156 Novartis Pharmaceuticals132 Fondazione IRCCS Policlinico San Matteo di Pavia120 Merck Sharp & Dohme LLC116 Istituto Ortopedico Rizzoli108 Hoffmann-La Roche106 Janssen Research & Development, LLC82 AbbVie77 Bristol-Myers Squibb74 European Institute of Oncology74 Eli Lilly and Company74 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico65 Sanofi63 Istituti Clinici Scientifici Maugeri SpA58 Pfizer56 GlaxoSmithKline48 Fondazione Don Carlo Gnocchi ETS48 Istituto Clinico Humanitas47 Mario Negri Institute for Pharmacological Research46 Istituto Auxologico Italiano45 IRCCS Policlinico S. Donato45 I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio45 Show all 1441 Clear sponsor filter
Site location
Milan16 Rome9 Naples8 Florence7 Meldola7 Pisa7 Genoa6 Rozzano5 Bologna5 Turin4 Candiolo4 Brescia4 Ferrara3 Ancona3 Bari3 Perugia3 Bergamo3 Novara3 Torino2 Cuneo2 Palermo2 Roma2 Monza2 Livorno2 Ravenna2 Show all 48
All 48 locations
Target enrolment
to

Trials in this register

24 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Regeneron Pharmaceuticals
Phase 3
35
Rome, Florence, Torino
2026-06-11
Recruiting
Regeneron Pharmaceuticals
Phase 2
120
Milan, Pieve Emanuele
2026-04-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Rome, Milan, Florence, Ancona
2024-10-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
19
Ferrara
2024-09-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Florence, Milan, Rozzano, Vicenza
2024-09-11
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
DrugDupilumab
Regeneron Pharmaceuticals
Phase 2
22
Rozzano, Palermo, Bari, Milan, Pisa, Roma, Rome
2023-05-03
Recruiting
Regeneron Pharmaceuticals
Phase 3
202
Florence, Torino
2023-03-07
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Ancona, Naples, Meldola, Milan, Bari, Cuneo, Perugia, Rome
2023-01-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
63
Genoa
2022-11-21
Active, closed
Regeneron Pharmaceuticals
Observational
509
Misterbianco, Florence, Udine, Rozzano, Orbassano, Pisa, Catania, Milan
2022-10-26
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Rome, Milan, Pisa, Bergamo, Roma
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Observational
717
Rozzano, Catania, Pisa, Siena, Padova, Catanzaro, Genova, Rome
2021-08-12
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Milan, Bologna, Livorno, Novara, Perugia, Ravenna, Reggio Emilia, Varese
2019-11-13
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Rome, Milan, Naples
2018-05-21
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Italy?

11 of the 24 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 24 studies
PhaseStudiesRecruitingShare
Phase 313754.2%
Phase 27229.2%
Observational208.3%
Phase 1/2228.3%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Regeneron Pharmaceuticals2411

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Melanoma (3) Paroxysmal Nocturnal Hemoglobinuria (2) Follicular Lymphoma (FL) (2) Hemophilia B (1) Non-Transfusion Dependent Beta-Thalassemia (NTDT) (1) Age-related Macular Degeneration (AMD) (1) Geographic Atrophy (GA) (1) Eosinophilic Gastritis (EoG) (1) Eosinophilic Duodenitis (EoD) (1) Eosinophilic Gastrointestinal Disease (EGID) (1) Eosinophilic Gastroenteritis (1) Relapsed/Refractory Follicular Lymphoma (1) Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) (1) Resectable Non-small Cell Lung Cancer (1) Cutaneous Squamous Cell Carcinoma (1)
→

Browse trials by site location

Milan (16) Rome (9) Naples (8) Florence (7) Meldola (7) Pisa (7) Genoa (6) Rozzano (5) Bologna (5) Turin (4) Candiolo (4) Brescia (4) Ferrara (3) Ancona (3) Bari (3)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.